1. Synthesis and biological properties of prodrugs of (S)-3-(adenin-9-yl)-2-(phosphonomethoxy)propanoic acid.
- Author
-
Kaiser MM, Poštová-Slavětínská L, Dračínský M, Lee YJ, Tian Y, and Janeba Z
- Subjects
- Adenine chemical synthesis, Adenine chemistry, Adenine pharmacology, Antiviral Agents chemical synthesis, Antiviral Agents chemistry, Dose-Response Relationship, Drug, Microbial Sensitivity Tests, Molecular Structure, Organophosphonates chemical synthesis, Organophosphonates chemistry, Prodrugs chemical synthesis, Prodrugs chemistry, Structure-Activity Relationship, Adenine analogs & derivatives, Antiviral Agents pharmacology, Hepacivirus drug effects, Organophosphonates pharmacology, Prodrugs pharmacology
- Abstract
The lack of antiviral activity of recently described (S)-3-(adenin-9-yl)-2-(phosphonomethoxy)propanoic acid, or (S)-CPMEA in brief, has been speculated to possibly be due to the increased hydrophilicity of the molecule and, thus, by its limited cellular permeability. Efficient syntheses of novel lipophilic prodrugs of (S)-CPMEA masking either the carboxylic group or preferably both the phosphonate and carboxylic moieties, have been developed in order to increase bioavailability of the parent compound. Two prodrugs of (S)-CPMEA, namely phosphonate bis-amidate 15 and phenyloxy amidate 16, exhibited pan-genotypic anti-HCV activity at submicromolar concentrations., (Copyright © 2015 Elsevier Masson SAS. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF